Nancy Gillis

2.1k total citations
33 papers, 797 citations indexed

About

Nancy Gillis is a scholar working on Hematology, Cancer Research and Molecular Biology. According to data from OpenAlex, Nancy Gillis has authored 33 papers receiving a total of 797 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Hematology, 8 papers in Cancer Research and 6 papers in Molecular Biology. Recurrent topics in Nancy Gillis's work include Acute Myeloid Leukemia Research (12 papers), Cancer Genomics and Diagnostics (8 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (5 papers). Nancy Gillis is often cited by papers focused on Acute Myeloid Leukemia Research (12 papers), Cancer Genomics and Diagnostics (8 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (5 papers). Nancy Gillis collaborates with scholars based in United States, United Kingdom and Puerto Rico. Nancy Gillis's co-authors include Michael A. Marletta, Stephen Rimar, Warren M. Zapol, Carol H. Bosken, Federico Innocenti, Howard L. McLeod, Flávio da Costa Fernandes, Eric A. Hoffman, Eric Padron and Linda J. Walters and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Nancy Gillis

25 papers receiving 777 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nancy Gillis United States 11 246 195 162 144 138 33 797
Tsewang Tashi United States 13 73 0.3× 64 0.3× 105 0.6× 84 0.6× 60 0.4× 47 555
Jennifer Smith United Kingdom 26 92 0.4× 386 2.0× 159 1.0× 59 0.4× 111 0.8× 50 2.0k
Margot Haun Austria 21 85 0.3× 97 0.5× 82 0.5× 135 0.9× 276 2.0× 39 1.0k
Alexi Crosby United Kingdom 20 104 0.4× 876 4.5× 144 0.9× 237 1.6× 183 1.3× 39 1.7k
Yoko Hirabayashi Japan 15 155 0.6× 166 0.9× 43 0.3× 209 1.5× 91 0.7× 57 942
Fiorella Alfinito Italy 18 186 0.8× 52 0.3× 186 1.1× 45 0.3× 185 1.3× 41 794
Patricia Fernández‐Llama Spain 24 250 1.0× 533 2.7× 65 0.4× 103 0.7× 101 0.7× 53 1.9k
Luís F. Quintana Spain 23 147 0.6× 406 2.1× 164 1.0× 30 0.2× 115 0.8× 84 1.5k
Masaru Yokoyama Japan 16 189 0.8× 55 0.3× 140 0.9× 69 0.5× 97 0.7× 50 917
Frederick W.K. Tam United Kingdom 17 38 0.2× 274 1.4× 100 0.6× 36 0.3× 97 0.7× 28 984

Countries citing papers authored by Nancy Gillis

Since Specialization
Citations

This map shows the geographic impact of Nancy Gillis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nancy Gillis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nancy Gillis more than expected).

Fields of papers citing papers by Nancy Gillis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nancy Gillis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nancy Gillis. The network helps show where Nancy Gillis may publish in the future.

Co-authorship network of co-authors of Nancy Gillis

This figure shows the co-authorship network connecting the top 25 collaborators of Nancy Gillis. A scholar is included among the top collaborators of Nancy Gillis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nancy Gillis. Nancy Gillis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gillis, Nancy, et al.. (2025). Cell State Transitions Drive the Evolution of Disease Progression in B-Lymphoblastic Leukemia. Cancer Research Communications. 6(1). 47–59.
2.
3.
DeZern, Amy E., Michael Otterstatter, Nancy Gillis, et al.. (2024). Progression of Myelodysplastic Syndromes in the MDS Natural History Study (MDS NHS). Blood. 144(Supplement 1). 1831–1831.
4.
Gillis, Nancy, Christelle Colin, Ryan M. Putney, et al.. (2024). Clonal Hematopoiesis in Patients With Human Immunodeficiency Virus and Cancer. The Journal of Infectious Diseases. 230(3). 680–688. 3 indexed citations
5.
Gillis, Nancy, et al.. (2024). Clinical impact of clonal hematopoiesis in hematopoietic cell transplantation: a review, metaanalysis, and call to action. Haematologica. 109(12). 3952–3964. 1 indexed citations
6.
Xie, Zhuoer, Michael Otterstatter, Ling Zhang, et al.. (2024). High-Risk Ccus Is Clinically Indistinguishable from Low-Risk Myelodysplastic Syndromes/Neoplasms. Blood. 144(Supplement 1). 354–354.
7.
Gillis, Nancy, Eric Padron, Tao Wang, et al.. (2023). Pilot Study of Donor-Engrafted Clonal Hematopoiesis Evolution and Clinical Outcomes in Allogeneic Hematopoietic Cell Transplantation Recipients Using a National Registry. Transplantation and Cellular Therapy. 29(10). 640.e1–640.e8. 4 indexed citations
8.
Williams, Kirsten M., Nancy Gillis, Kelly L. Bolton, et al.. (2023). Donor-Derived Malignancy and Transplantation Morbidity: Risks of Patient and Donor Genetics in Allogeneic Hematopoietic Stem Cell Transplantation. Transplantation and Cellular Therapy. 30(3). 255–267. 10 indexed citations
9.
Gillis, Nancy, Amy S. Etheridge, D. Neil Hayes, et al.. (2023). Sequencing of genes of drug response in tumor DNA and implications for precision medicine in cancer patients. The Pharmacogenomics Journal. 23(4). 73–81. 2 indexed citations
10.
Colin, Christelle, Rahul Mhaskar, Shridar Ganesan, et al.. (2023). Clonal Hematopoiesis as a Molecular Risk Factor for Doxorubicin-Induced Cardiotoxicity: A Proof-of-Concept Study. JCO Precision Oncology. 7(7). e2300208–e2300208. 4 indexed citations
11.
Abel, Gregory A., Dana E. Rollison, Nancy Gillis, et al.. (2023). Health-related quality of life and vulnerability among people with myelodysplastic syndromes: a US national study. Blood Advances. 7(14). 3506–3515. 6 indexed citations
12.
Braithwaite, Dejana, Stephen D. Anton, Supriya G. Mohile, et al.. (2022). Cancer and aging: A call to action. SHILAP Revista de lepidopterología. 3(2). 87–94. 8 indexed citations
13.
Gillis, Nancy, et al.. (2017). Incidence and Triggers of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in a Large Cancer Patient Cohort. Journal of Investigative Dermatology. 137(9). 2021–2023. 22 indexed citations
14.
Gillis, Nancy & Howard L. McLeod. (2016). The pharmacogenomics of drug resistance to protein kinase inhibitors. Drug Resistance Updates. 28. 28–42. 19 indexed citations
15.
Gillis, Nancy & Federico Innocenti. (2014). Evidence Required to Demonstrate Clinical Utility of Pharmacogenetic Testing: The Debate Continues. Clinical Pharmacology & Therapeutics. 96(6). 655–657. 36 indexed citations
16.
McDonough, Caitrin W., Nancy Gillis, Abdullah Alsultan, et al.. (2013). Atenolol Induced HDL-C Change in the Pharmacogenomic Evaluation of Antihypertensive Responses (PEAR) Study. PLoS ONE. 8(10). e76984–e76984. 11 indexed citations
17.
Gillis, Nancy, et al.. (2013). Clinical Implementation of Germ Line Cancer Pharmacogenetic Variants During the Next-Generation Sequencing Era. Clinical Pharmacology & Therapeutics. 95(3). 269–280. 43 indexed citations
18.
Gillis, Nancy, Linda J. Walters, Flávio da Costa Fernandes, & Eric A. Hoffman. (2009). Higher genetic diversity in introduced than in native populations of the mussel Mytella charruana: evidence of population admixture at introduction sites. Diversity and Distributions. 15(5). 784–795. 79 indexed citations
19.
Zapol, Warren M., Stephen Rimar, Nancy Gillis, Michael A. Marletta, & Carol H. Bosken. (1994). Nitric Oxide and the Lung. American Journal of Respiratory and Critical Care Medicine. 149(5). 1375–1380. 217 indexed citations
20.
Maack, Thomas, et al.. (1986). Removal of atrial natriuretic factor by perfused rabbit lungs in situ. Federation Proceedings. 45(4). 1127. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tsewang Tashi Breakdown of academic impact, for papers by Jennifer Smith Breakdown of academic impact, for papers by Margot Haun Breakdown of academic impact, for papers by Alexi Crosby Breakdown of academic impact, for papers by Yoko Hirabayashi Breakdown of academic impact, for papers by Fiorella Alfinito Breakdown of academic impact, for papers by Patricia Fernández‐Llama Breakdown of academic impact, for papers by Luís F. Quintana Breakdown of academic impact, for papers by Masaru Yokoyama Breakdown of academic impact, for papers by Frederick W.K. Tam
Rankless by CCL
2026